Dear members, colleagues, and friends,
I am delighted to invite you to the 27th Annual Scientific Meeting of the International Society of Cardiovascular Pharmacotherapy (ISCP), which this year will come to Bucharest, Romania. Of note, this meeting will provide the possibility of onsite as well as online participation, aiming to meet the needs of all colleagues from around the world.
The meeting will be an integrated scaffold of learning, sharing knowledge, and breakthrough science. The scientific programme will cover many aspects of cardiology and cardiovascular medicine, with focus on cardiovascular pharmacology and pharmacotherapy, ranging from basic pharmacology over clinical trials to clinical pharmacology. We will offer a diverse and extensive scientific program, with state-of-the-art lectures, debates and round table discussions, poster sessions, and educational courses. Thus, we look forward to welcome physicians, pharmacologists, pharmacists, nurses, scientists, researchers, allied health care professionals, and all other interested to attend.
The International Society of Cardiovascular Pharmacotherapy is a global non-governmental, not-for-profit organisation with the objective to facilitate appropriate and effective clinical use of pharmacotherapy through the promotion of research and education with the goal to improve prevention and treatment, and ultimately improve cardiovascular health.
I am looking forward welcoming you in Bucharest.
Prof. Thomas Kahan, MD, PhD, FAHA, FESC
President of ISCP
The International Society of Cardiovascular Pharmacotherapy (ISCP) is a global organisation, affiliated to the World Heart Federation, whose mission is to promote and facilitate strategies to improve cardiovascular health through rational pharmacotherapy. ISCP represents a forum for dialogue and cooperation among cardiac physicians, pharmacologists, pharmacists, scientists with an interest in cardiovascular pharmacology, and health care professionals in general.
ISCP promotes education, research and evidence-based clinical management in all areas of cardiovascular pharmacotherapy with the ultimate goal of prevention and improving treatment, outcome and patient wellbeing.